Vasopressin receptor antagonists for the treatment of hyponatremia: Systematic review and meta-analysis

Keyphrases

• Adverse Event Rates 20%
• Adverse Events 20%
• Antagonist Treatment 20%
• Change from Baseline 40%
• Effect Estimates 20%
• Euvolemic 20%
• Euvolemic Hyponatremia 60%
• Fluid Restriction 40%
• Hypernatremia 40%
• Hypervolemic 20%
• Hypervolemic Hyponatremia 60%
• Hyponatremia 100%
• Language of Publication 20%
• Late Effects 20%
• Meta-analysis 100%
• Meta-analysis of Randomized Controlled Trials 20%
• No-report 20%
• Osmotic Demyelination Syndrome 20%
• Placebo 20%
• Publication Status 20%
• Randomized Controlled Trial 40%
• Response Rate 60%
• Response-outcome 20%
• Selection Criteria 20%
• Serum Sodium 80%
• Sodium Correction 20%
• Sodium Levels 20%
• Systematic Meta-analysis 100%
• Vasopressin Antagonists 100%
• Vasopressin Receptor Antagonists 100%
• Weighted Mean Difference 40%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Event 40%
• Demyelination 20%
• Hypernatremia 40%
• Hyponatremia 100%
• Placebo 20%
• Randomized Controlled Trial 60%
• Syndrome 20%
• Vasopressin Antagonist 100%
• Vasopressin Receptor Antagonist 100%